Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.
Kloten, V
Neumann, MHD
Di Pasquale, F
Sprenger-Haussels, M
Shaffer, JM
Schlumpberger, M
Herdean, A
Betsou, F
Ammerlaan, W
Af Hällström, T
Serkkola, E
Forsman, T
Lianidou, E
Sjöback, R
Kubista, M
Bender, S
Lampignano, R
Krahn, T
Schlange, T
CANCER-ID consortium,
- Publisher:
- AMER ASSOC CLINICAL CHEMISTRY
- Publication Type:
- Journal Article
- Citation:
- Clin Chem, 2019, 65, (9), pp. 1132-1140
- Issue Date:
- 2019-09
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
7907234 (2).pdf | Published version | 1.64 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Kloten, V | |
dc.contributor.author | Neumann, MHD | |
dc.contributor.author | Di Pasquale, F | |
dc.contributor.author | Sprenger-Haussels, M | |
dc.contributor.author | Shaffer, JM | |
dc.contributor.author | Schlumpberger, M | |
dc.contributor.author |
Herdean, A https://orcid.org/0000-0003-2143-0213 |
|
dc.contributor.author | Betsou, F | |
dc.contributor.author | Ammerlaan, W | |
dc.contributor.author | Af Hällström, T | |
dc.contributor.author | Serkkola, E | |
dc.contributor.author | Forsman, T | |
dc.contributor.author | Lianidou, E | |
dc.contributor.author | Sjöback, R | |
dc.contributor.author | Kubista, M | |
dc.contributor.author | Bender, S | |
dc.contributor.author | Lampignano, R | |
dc.contributor.author | Krahn, T | |
dc.contributor.author | Schlange, T | |
dc.contributor.author | CANCER-ID consortium, | |
dc.date.accessioned | 2022-08-15T06:09:28Z | |
dc.date.available | 2019-05-20 | |
dc.date.available | 2022-08-15T06:09:28Z | |
dc.date.issued | 2019-09 | |
dc.identifier.citation | Clin Chem, 2019, 65, (9), pp. 1132-1140 | |
dc.identifier.issn | 0009-9147 | |
dc.identifier.issn | 1530-8561 | |
dc.identifier.uri | http://hdl.handle.net/10453/160225 | |
dc.description.abstract | BACKGROUND: In human body fluids, microRNA (miRNA) can be found as circulating cell-free miRNA (cfmiRNA), as well as secreted into extracellular vesicles (EVmiRNA). miRNAs are being intensively evaluated as minimally invasive liquid biopsy biomarkers in patients with cancer. The growing interest in developing clinical assays for circulating miRNA necessitates careful consideration of confounding effects of preanalytical and analytical parameters. METHODS: By using reverse transcription quantitative real-time PCR and next-generation sequencing (NGS), we compared extraction efficiencies of 5 different protocols for cfmiRNA and 2 protocols for EVmiRNA isolation in a multicentric manner. The efficiency of the different extraction methods was evaluated by measuring exogenously spiked cel-miR-39 and 6 targeted miRNAs in plasma from 20 healthy individuals. RESULTS: There were significant differences between the tested methods. Although column-based extraction methods were highly effective for the isolation of endogenous miRNA, phenol extraction combined with column-based miRNA purification and ultracentrifugation resulted in lower quality and quantity of isolated miRNA. Among all extraction methods, the ubiquitously expressed miR-16 was represented with high abundance when compared with other targeted miRNAs. In addition, the use of miR-16 as an endogenous control for normalization of quantification cycle values resulted in a decreased variability of column-based cfmiRNA extraction methods. Cluster analysis of normalized NGS counts clearly indicated a method-dependent bias. CONCLUSIONS: The choice of plasma miRNA extraction methods affects the selection of potential miRNA marker candidates and mechanistic interpretation of results, which should be done with caution, particularly across studies using different protocols. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | AMER ASSOC CLINICAL CHEMISTRY | |
dc.relation.ispartof | Clin Chem | |
dc.relation.isbasedon | 10.1373/clinchem.2019.303271 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 1004 Medical Biotechnology, 1101 Medical Biochemistry and Metabolomics, 1103 Clinical Sciences | |
dc.subject.classification | General Clinical Medicine | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Biomarkers, Tumor | |
dc.subject.mesh | Caenorhabditis elegans | |
dc.subject.mesh | Chemical Fractionation | |
dc.subject.mesh | Circulating MicroRNA | |
dc.subject.mesh | Extracellular Vesicles | |
dc.subject.mesh | Female | |
dc.subject.mesh | High-Throughput Nucleotide Sequencing | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Real-Time Polymerase Chain Reaction | |
dc.subject.mesh | Reverse Transcriptase Polymerase Chain Reaction | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Caenorhabditis elegans | |
dc.subject.mesh | Chemical Fractionation | |
dc.subject.mesh | Reverse Transcriptase Polymerase Chain Reaction | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Female | |
dc.subject.mesh | Male | |
dc.subject.mesh | High-Throughput Nucleotide Sequencing | |
dc.subject.mesh | Real-Time Polymerase Chain Reaction | |
dc.subject.mesh | Extracellular Vesicles | |
dc.subject.mesh | Biomarkers, Tumor | |
dc.subject.mesh | Circulating MicroRNA | |
dc.title | Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows. | |
dc.type | Journal Article | |
utslib.citation.volume | 65 | |
utslib.location.activity | England | |
utslib.for | 1004 Medical Biotechnology | |
utslib.for | 1101 Medical Biochemistry and Metabolomics | |
utslib.for | 1103 Clinical Sciences | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Strength - C3 - Climate Change Cluster | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2022-08-15T06:09:14Z | |
pubs.issue | 9 | |
pubs.publication-status | Published | |
pubs.volume | 65 | |
utslib.citation.issue | 9 |
Abstract:
BACKGROUND: In human body fluids, microRNA (miRNA) can be found as circulating cell-free miRNA (cfmiRNA), as well as secreted into extracellular vesicles (EVmiRNA). miRNAs are being intensively evaluated as minimally invasive liquid biopsy biomarkers in patients with cancer. The growing interest in developing clinical assays for circulating miRNA necessitates careful consideration of confounding effects of preanalytical and analytical parameters. METHODS: By using reverse transcription quantitative real-time PCR and next-generation sequencing (NGS), we compared extraction efficiencies of 5 different protocols for cfmiRNA and 2 protocols for EVmiRNA isolation in a multicentric manner. The efficiency of the different extraction methods was evaluated by measuring exogenously spiked cel-miR-39 and 6 targeted miRNAs in plasma from 20 healthy individuals. RESULTS: There were significant differences between the tested methods. Although column-based extraction methods were highly effective for the isolation of endogenous miRNA, phenol extraction combined with column-based miRNA purification and ultracentrifugation resulted in lower quality and quantity of isolated miRNA. Among all extraction methods, the ubiquitously expressed miR-16 was represented with high abundance when compared with other targeted miRNAs. In addition, the use of miR-16 as an endogenous control for normalization of quantification cycle values resulted in a decreased variability of column-based cfmiRNA extraction methods. Cluster analysis of normalized NGS counts clearly indicated a method-dependent bias. CONCLUSIONS: The choice of plasma miRNA extraction methods affects the selection of potential miRNA marker candidates and mechanistic interpretation of results, which should be done with caution, particularly across studies using different protocols.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph